FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

December 31, 2026

Conditions
Urinary Bladder Neoplasms
Interventions
PROCEDURE

imaging examinations:FAPI PET/MRI, FDG PET/MRI, MRI

"FAPI PET/MRI and FDG PET/MRI examination Data acquisition was performed using a GE Healthcare SIGNA PET/MR instrument. Enrolled patients were injected intravenously with 68Ga-FAPI or 18F-FDG tracer and underwent simultaneous PET and MRI scanning approximately 30-60 minutes after intravenous administration of the tracer at a dose of 1.85-3.7 MBq/kg.~MRI examination MRI examination was performed using a Skyra 3.0T MRI scanner from Siemens, Germany, with a 16-channel phased-array surface coil, and the scanning range was from the superior margin of the iliac wing to the inferior margin of the pubic symphysis."

Trial Locations (1)

350005

RECRUITING

first hospital affiliated of Fujian medical university, Fuzhou

All Listed Sponsors
lead

First Affiliated Hospital of Fujian Medical University

OTHER